{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:25Z","timestamp":1792787905086,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Xiaowu Zhu famous doctor studio","award":["NO.CY2019002"],"award-info":[{"award-number":["NO.CY2019002"]}]},{"name":"Xiaowu Zhu famous doctor studio","award":["NO.CY2019002"],"award-info":[{"award-number":["NO.CY2019002"]}]},{"name":"Xiaowu Zhu famous doctor studio","award":["NO.CY2019002"],"award-info":[{"award-number":["NO.CY2019002"]}]},{"name":"Xiaowu Zhu famous doctor studio","award":["NO.CY2019002"],"award-info":[{"award-number":["NO.CY2019002"]}]},{"name":"Xiaowu Zhu famous doctor studio","award":["NO.CY2019002"],"award-info":[{"award-number":["NO.CY2019002"]}]},{"name":"Xiaowu Zhu famous doctor studio","award":["NO.CY2019002"],"award-info":[{"award-number":["NO.CY2019002"]}]},{"name":"Xiaowu Zhu famous doctor studio","award":["NO.CY2019002"],"award-info":[{"award-number":["NO.CY2019002"]}]},{"name":"Xiaowu Zhu famous doctor studio","award":["NO.CY2019002"],"award-info":[{"award-number":["NO.CY2019002"]}]},{"name":"Xiaowu Zhu famous doctor studio","award":["NO.CY2019002"],"award-info":[{"award-number":["NO.CY2019002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-024-09895-9","type":"journal-article","created":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T07:01:55Z","timestamp":1726815715000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Clinical characteristics and prognostic factors of pulmonary and extrapulmonary cryptococcosis"],"prefix":"10.1186","volume":"24","author":[{"given":"Ziwei","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinqin","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongli","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sicheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanyou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,20]]},"reference":[{"key":"9895_CR1","doi-asserted-by":"publisher","first-page":"804674","DOI":"10.3389\/fimmu.2022.804674","volume":"13","author":"SH Mohamed","year":"2022","unstructured":"Mohamed SH, Nyazika TK, Ssebambulidde K, Lionakis MS, Meya DB, Drummond RA. Fungal CNS infections in Africa: the Neuroimmunology of Cryptococcal Meningitis. Front Immunol. 2022;13:804674.","journal-title":"Front Immunol"},{"issue":"6","key":"9895_CR2","first-page":"438","volume":"19","author":"T Suwatanapongched","year":"2013","unstructured":"Suwatanapongched T, Sangsatra W, Boonsarngsuk V, Watcharananan SP, Incharoen P. Clinical and radiologic manifestations of pulmonary cryptococcosis in immunocompetent patients and their outcomes after treatment. Diagn Interv Radiol. 2013;19(6):438\u201346.","journal-title":"Diagn Interv Radiol"},{"issue":"4","key":"9895_CR3","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1159\/000357715","volume":"87","author":"L Sun","year":"2014","unstructured":"Sun L, Chen H, Shao C, Song Y, Bai C. Pulmonary cryptococcosis with trachea wall invasion in an immunocompetent patient: a case report and literature review. Respiration. 2014;87(4):324\u20138.","journal-title":"Respiration"},{"issue":"1","key":"9895_CR4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/s12879-017-2450-5","volume":"17","author":"LW Gao","year":"2017","unstructured":"Gao LW, Jiao AX, Wu XR, Zhao SY, Ma Y, Liu G, et al. Clinical characteristics of disseminated cryptococcosis in previously healthy children in China. BMC Infect Dis. 2017;17(1):359.","journal-title":"BMC Infect Dis"},{"issue":"12","key":"9895_CR5","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s40265-022-01757-5","volume":"82","author":"NTT Ngan","year":"2022","unstructured":"Ngan NTT, Flower B, Day JN. Treatment of cryptococcal meningitis: how have we got Here and where are we. Going? Drugs. 2022;82(12):1237\u201349.","journal-title":"Going? Drugs"},{"issue":"4","key":"9895_CR6","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3109\/13693780903437876","volume":"48","author":"LP Zhu","year":"2010","unstructured":"Zhu LP, Wu JQ, Xu B, Ou XT, Zhang QQ, Weng XH. Cryptococcal meningitis in non-HIV-infected patients in a Chinese tertiary care hospital, 1997\u20132007. Med Mycol. 2010;48(4):570\u20139.","journal-title":"Med Mycol"},{"issue":"5","key":"9895_CR7","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3201\/eid1405.071312","volume":"14","author":"J Chen","year":"2008","unstructured":"Chen J, Varma A, Diaz MR, Litvintseva AP, Wollenberg KK, Kwon-Chung KJ. Cryptococcus neoformans strains and infection in apparently immunocompetent patients, China. Emerg Infect Dis. 2008;14(5):755\u201362.","journal-title":"Emerg Infect Dis"},{"key":"9895_CR8","doi-asserted-by":"crossref","unstructured":"Li Z, Liu Y, Cao H, Huang S, Long M. Epidemiology and clinical characteristics of cryptococcal meningitis in China (1981\u20132013): a review of the literature. Med Mycology: Open Access. 2017;03(01).","DOI":"10.21767\/2471-8203.100022"},{"issue":"9","key":"9895_CR9","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.3201\/eid2609.200016","volume":"26","author":"L-H Zhou","year":"2020","unstructured":"Zhou L-H, Jiang Y-K, Li R-Y, Huang L-P, Yip C-W, Denning DW, et al. Risk-based Estimate of Human Fungal Disease Burden, China. Emerg Infect Dis. 2020;26(9):2137\u201347.","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"9895_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/mmy\/myy086","volume":"57","author":"F Setianingrum","year":"2019","unstructured":"Setianingrum F, Rautemaa-Richardson R, Denning D. Pulmonary cryptococcosis: a review of pathobiology and clinical aspects. Med Mycol. 2019;57(2):133\u201350.","journal-title":"Med Mycol"},{"issue":"6","key":"9895_CR11","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","volume":"71","author":"J Donnelly","year":"2020","unstructured":"Donnelly J, Chen S, Kauffman C, Steinbach W, Baddley J, Verweij P, et al. Revision and update of the Consensus definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2020;71(6):1367\u201376.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"issue":"2","key":"9895_CR12","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/cid\/ciz193","volume":"70","author":"K Marr","year":"2020","unstructured":"Marr K, Sun Y, Spec A, Lu N, Panackal A, Bennett J, et al. A Multicenter, Longitudinal Cohort Study of Cryptococcosis in Human Immunodeficiency Virus-negative people in the United States. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2020;70(2):252\u201361.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"key":"9895_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fmed.2019.00129","volume":"6","author":"D Decote-Ricardo","year":"2019","unstructured":"Decote-Ricardo D, LaRocque-de-Freitas IF, Rocha JDB, Nascimento DO, Nunes MP, Morrot A, et al. Immunomodulatory Role of Capsular Polysaccharides constituents of Cryptococcus neoformans. Front Med (Lausanne). 2019;6:129.","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"9895_CR14","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3390\/jof10050339","volume":"10","author":"IF Larocque-De-Freitas","year":"2024","unstructured":"Larocque-De-Freitas IF, Da Silva-Junior EB, Gemieski LP, Da Silva Dias Lima B, Diniz-Lima I, De Carvalho Vivarini A, et al. Inhibition of Microbicidal Activity of Canine macrophages DH82 Cell line by Capsular polysaccharides from Cryptococcus neoformans. J Fungi. 2024;10(5):339.","journal-title":"J Fungi"},{"key":"9895_CR15","doi-asserted-by":"crossref","unstructured":"Larocque-De-Freitas IF, Rocha JDB, Nunes MP, Oliveira PAV, Nascimento DDO, Freire-De-Lima L et al. Involvement of the capsular GalXM-induced IL-17 cytokine in the control of Cryptococcus neoformans infection. Sci Rep. 2018;8(1).","DOI":"10.1038\/s41598-018-34649-4"},{"issue":"6","key":"9895_CR16","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1111\/j.1462-5822.2008.01125.x","volume":"10","author":"SN Villena","year":"2008","unstructured":"Villena SN, Pinheiro RO, Pinheiro CS, Nunes MP, Takiya CM, DosReis GA, et al. Capsular polysaccharides galactoxylomannan and glucuronoxylomannan from Cryptococcus neoformans induce macrophage apoptosis mediated by Fas ligand. Cell Microbiol. 2008;10(6):1274\u201385.","journal-title":"Cell Microbiol"},{"issue":"10","key":"9895_CR17","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1111\/j.1462-5822.2008.01196.x","volume":"10","author":"C Monari","year":"2008","unstructured":"Monari C, Paganelli F, Bistoni F, Kozel TR, Vecchiarelli A. Capsular polysaccharide induction of apoptosis by intrinsic and extrinsic mechanisms. Cell Microbiol. 2008;10(10):2129\u201337.","journal-title":"Cell Microbiol"},{"issue":"6","key":"9895_CR18","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.4049\/jimmunol.174.6.3461","volume":"174","author":"C Monari","year":"2005","unstructured":"Monari C, Pericolini E, Bistoni G, Casadevall A, Kozel TR, Vecchiarelli A. Cryptococcus neoformans capsular glucuronoxylomannan induces expression of fas ligand in macrophages. J Immunol. 2005;174(6):3461\u20138.","journal-title":"J Immunol"},{"key":"9895_CR19","doi-asserted-by":"crossref","unstructured":"Lin C, Yang TY, Chan MC, Hsu KH, Huang YH, Tseng JS. Comprehensive Analysis and Risk Identification of Pulmonary Cryptococcosis in Non-HIV patients. J Fungi (Basel). 2021;7(8).","DOI":"10.3390\/jof7080657"},{"key":"9895_CR20","first-page":"244","volume":"128","author":"Y Tian","year":"2023","unstructured":"Tian Y, Wang J, Shen Y, Zhao J, Hu J, Zhu X, et al. Characteristics and prognostic risk factors of patients with sequence type 5 lineage-associated cryptococcosis in China. Int J Infect Diseases: IJID : Official Publication Int Soc Infect Dis. 2023;128:244\u201353.","journal-title":"Int J Infect Diseases: IJID : Official Publication Int Soc Infect Dis"},{"key":"9895_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1742-2094-10-71","volume":"10","author":"S Redlich","year":"2013","unstructured":"Redlich S, Ribes S, Sch\u00fctze S, Eiffert H, Nau R. Toll-like receptor stimulation increases phagocytosis of Cryptococcus neoformans by microglial cells. J Neuroinflammation. 2013;10:71.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"9895_CR22","doi-asserted-by":"publisher","first-page":"5712","DOI":"10.1038\/s41598-022-09794-6","volume":"12","author":"DX Wang","year":"2022","unstructured":"Wang DX, Zhang Q, Wen QT, Ding GX, Wang YG, Du FX, et al. Comparison of CT findings and histopathological characteristics of pulmonary cryptococcosis in immunocompetent and immunocompromised patients. Sci Rep. 2022;12(1):5712.","journal-title":"Sci Rep"},{"issue":"8","key":"9895_CR23","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.4049\/jimmunol.1103455","volume":"189","author":"SE Hardison","year":"2012","unstructured":"Hardison SE, Herrera G, Young ML, Hole CR, Wozniak KL, Wormley FL. Jr. Protective immunity against pulmonary cryptococcosis is associated with STAT1-mediated classical macrophage activation. J Immunol. 2012;189(8):4060\u20138.","journal-title":"J Immunol"},{"issue":"2","key":"9895_CR24","doi-asserted-by":"publisher","first-page":"583","DOI":"10.4049\/jimmunol.1700958","volume":"201","author":"CM De Leon-Rodriguez","year":"2018","unstructured":"De Leon-Rodriguez CM, Rossi DCP, Fu MS, Dragotakes Q, Coelho C, Guerrero Ros I, et al. The outcome of the Cryptococcus neoformans-Macrophage Interaction depends on phagolysosomal membrane Integrity. J Immunol. 2018;201(2):583\u2013603.","journal-title":"J Immunol"},{"issue":"1","key":"9895_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1471-2172-8-16","volume":"8","author":"M Alvarez","year":"2007","unstructured":"Alvarez M, Casadevall A. Cell-to-cell spread and massive vacuole formation after Cryptococcus neoformans infection of murine macrophages. BMC Immunol. 2007;8(1):16.","journal-title":"BMC Immunol"},{"issue":"5","key":"9895_CR26","doi-asserted-by":"publisher","first-page":"e1002047","DOI":"10.1371\/journal.ppat.1002047","volume":"7","author":"CJ Chrisman","year":"2011","unstructured":"Chrisman CJ, Albuquerque P, Guimaraes AJ, Nieves E, Casadevall A. Phospholipids trigger Cryptococcus neoformans capsular enlargement during interactions with amoebae and macrophages. PLoS Pathog. 2011;7(5):e1002047.","journal-title":"PLoS Pathog"},{"issue":"16","key":"9895_CR27","doi-asserted-by":"publisher","first-page":"8841","DOI":"10.1073\/pnas.97.16.8841","volume":"97","author":"C Nathan","year":"2000","unstructured":"Nathan C, Shiloh MU. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci U S A. 2000;97(16):8841\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"9895_CR28","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.4049\/jimmunol.1400318","volume":"193","author":"CM Leopold Wager","year":"2014","unstructured":"Leopold Wager CM, Hole CR, Wozniak KL, Olszewski MA, Wormley FL. Jr. STAT1 signaling is essential for protection against Cryptococcus neoformans infection in mice. J Immunol. 2014;193(8):4060\u201371.","journal-title":"J Immunol"},{"issue":"12","key":"9895_CR29","doi-asserted-by":"publisher","first-page":"4513","DOI":"10.1128\/IAI.00935-15","volume":"83","author":"CM Leopold Wager","year":"2015","unstructured":"Leopold Wager CM, Hole CR, Wozniak KL, Olszewski MA, Mueller M, Wormley FL. Jr. STAT1 signaling within macrophages is required for antifungal activity against Cryptococcus neoformans. Infect Immun. 2015;83(12):4513\u201327.","journal-title":"Infect Immun"},{"key":"9895_CR30","doi-asserted-by":"crossref","unstructured":"Campuzano A, Castro-Lopez N, Martinez AJ, Olszewski MA, Ganguly A, Leopold Wager C et al. CARD9 is required for classical macrophage activation and the induction of protective immunity against Pulmonary Cryptococcosis. mBio. 2020;11(1).","DOI":"10.1128\/mBio.03005-19"},{"issue":"6","key":"9895_CR31","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/myc.13247","volume":"64","author":"GM Viola","year":"2021","unstructured":"Viola GM, Malek AE, Rosen LB, DiNardo AR, Nishiguchi T, Okhuysen PC, et al. Disseminated cryptococcosis and anti-granulocyte-macrophage colony-stimulating factor autoantibodies: an underappreciated association. Mycoses. 2021;64(6):576\u201382.","journal-title":"Mycoses"},{"issue":"5","key":"9895_CR32","doi-asserted-by":"publisher","first-page":"e23191","DOI":"10.1002\/jcla.23191","volume":"34","author":"Q Han","year":"2020","unstructured":"Han Q, Wen X, Wang L, Han X, Shen Y, Cao J, et al. Role of hematological parameters in the diagnosis of influenza virus infection in patients with respiratory tract infection symptoms. J Clin Lab Anal. 2020;34(5):e23191.","journal-title":"J Clin Lab Anal"},{"key":"9895_CR33","doi-asserted-by":"publisher","first-page":"639735","DOI":"10.3389\/fimmu.2021.639735","volume":"12","author":"S Liu","year":"2021","unstructured":"Liu S, Wang X, She F, Zhang W, Liu H, Zhao X. Effects of Neutrophil-to-lymphocyte ratio combined with Interleukin-6 in Predicting 28-Day mortality in patients with Sepsis. Front Immunol. 2021;12:639735.","journal-title":"Front Immunol"},{"issue":"6","key":"9895_CR34","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s11046-021-00553-1","volume":"186","author":"K Zhang","year":"2021","unstructured":"Zhang K, Li H, Zhang L, Liao W, Cai L, Li X, et al. The change in the Neutrophil\/Lymphocyte ratio predicts the prognosis of patients with cryptococcal meningitis. Mycopathologia. 2021;186(6):857\u201362.","journal-title":"Mycopathologia"},{"key":"9895_CR35","doi-asserted-by":"publisher","first-page":"895456","DOI":"10.3389\/fimmu.2022.895456","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wei H, Shen L, Su X, Liu J, Xu X, et al. Immunological predictors of Post Infectious Inflammatory Response Syndrome in HIV-Negative immunocompetent cryptococcal meningitis. Front Immunol. 2022;13:895456.","journal-title":"Front Immunol"},{"issue":"1","key":"9895_CR36","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12890-023-02578-2","volume":"23","author":"J Shi","year":"2023","unstructured":"Shi J, Chen J, Hu L, Ma AHY, Hu H, Wang C, et al. Retrospective analysis of pulmonary cryptococcosis and extrapulmonary cryptococcosis in a Chinese tertiary hospital. BMC Pulm Med. 2023;23(1):277.","journal-title":"BMC Pulm Med"},{"issue":"6","key":"9895_CR37","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1002\/eji.200323626","volume":"33","author":"AJ Mednick","year":"2003","unstructured":"Mednick AJ, Feldmesser M, Rivera J, Casadevall A. Neutropenia alters lung cytokine production in mice and reduces their susceptibility to pulmonary cryptococcosis. Eur J Immunol. 2003;33(6):1744\u201353.","journal-title":"Eur J Immunol"},{"issue":"1","key":"9895_CR38","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1471-2172-13-65","volume":"13","author":"KL Wozniak","year":"2012","unstructured":"Wozniak KL, Kolls JK, Wormley FL. Depletion of neutrophils in a protective model of pulmonary cryptococcosis results in increased IL-17A production by gamma\/delta T cells. BMC Immunol. 2012;13(1):65.","journal-title":"BMC Immunol"},{"key":"9895_CR39","doi-asserted-by":"publisher","first-page":"680134","DOI":"10.3389\/fimmu.2021.680134","volume":"12","author":"J Hazeldine","year":"2021","unstructured":"Hazeldine J, Lord J. Neutrophils and COVID-19: active participants and rational therapeutic targets. Front Immunol. 2021;12:680134.","journal-title":"Front Immunol"},{"issue":"1","key":"9895_CR40","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41392-020-00243-2","volume":"5","author":"L Yang","year":"2020","unstructured":"Yang L, Liu S, Liu J, Zhang Z, Wan X, Huang B, et al. COVID-19: immunopathogenesis and immunotherapeutics. Signal Transduct Target Therapy. 2020;5(1):128.","journal-title":"Signal Transduct Target Therapy"},{"issue":"4","key":"9895_CR41","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","volume":"8","author":"Z Xu","year":"2020","unstructured":"Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respiratory Med. 2020;8(4):420\u201322.","journal-title":"Lancet Respiratory Med"},{"issue":"6","key":"9895_CR42","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/myc.13261","volume":"64","author":"H Zhao","year":"2021","unstructured":"Zhao H, Zhou M, Zheng Q, Zhu M, Yang Z, Hu C, et al. Clinical features and outcomes of Cryptococcemia patients with and without HIV infection. Mycoses. 2021;64(6):656\u201367.","journal-title":"Mycoses"},{"issue":"2","key":"9895_CR43","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10096-015-2545-0","volume":"35","author":"H Zheng","year":"2016","unstructured":"Zheng H, Chen Q, Xie Z, Wang D, Li M, Zhang X, et al. A retrospective research of HIV-negative cryptococcal meningoencephalitis patients with acute\/subacute onset. Eur J Clin Microbiol Infect Dis. 2016;35(2):299\u2013303.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"9895_CR44","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12879-023-08137-8","volume":"23","author":"S Liu","year":"2023","unstructured":"Liu S, Chen W, Cheng F, Ye X, Pan N, Lu H. Clinical characteristics and prognostic factors of 60 patients with acquired immune deficiency syndrome combined with Cryptococcus neoformans. BMC Infect Dis. 2023;23(1):204.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"9895_CR45","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1128\/IAI.72.9.4985-4995.2004","volume":"72","author":"Y Chang","year":"2004","unstructured":"Chang Y, Stins M, McCaffery M, Miller G, Pare D, Dam T, et al. Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the blood-brain barrier. Infect Immun. 2004;72(9):4985\u201395.","journal-title":"Infect Immun"},{"key":"9895_CR46","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1099\/mic.0.051524-0","volume":"158","author":"J Stie","year":"2012","unstructured":"Stie J, Fox D. Blood-brain barrier invasion by Cryptococcus neoformans is enhanced by functional interactions with plasmin. Microbiology. 2012;158:240\u201358.","journal-title":"Microbiology"},{"issue":"2","key":"9895_CR47","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4161\/viru.18685","volume":"3","author":"T Liu","year":"2012","unstructured":"Liu T, Perlin D, Xue C. Molecular mechanisms of cryptococcal meningitis. Virulence. 2012;3(2):173\u201381.","journal-title":"Virulence"},{"issue":"4","key":"9895_CR48","doi-asserted-by":"publisher","first-page":"e35455","DOI":"10.1371\/journal.pone.0035455","volume":"7","author":"W Sabiiti","year":"2012","unstructured":"Sabiiti W, May R. Capsule independent uptake of the fungal pathogen Cryptococcus neoformans into brain microvascular endothelial cells. PLoS ONE. 2012;7(4):e35455.","journal-title":"PLoS ONE"},{"issue":"19","key":"9895_CR49","doi-asserted-by":"publisher","first-page":"15298","DOI":"10.1074\/jbc.M112.353375","volume":"287","author":"A Jong","year":"2012","unstructured":"Jong A, Wu C, Gonzales-Gomez I, Kwon-Chung K, Chang Y, Tseng H, et al. Hyaluronic acid receptor CD44 deficiency is associated with decreased Cryptococcus neoformans brain infection. J Biol Chem. 2012;287(19):15298\u2013306.","journal-title":"J Biol Chem"},{"issue":"6","key":"9895_CR50","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1111\/j.1462-5822.2008.01128.x","volume":"10","author":"A Jong","year":"2008","unstructured":"Jong A, Wu C-H, Shackleford GM, Kwon-Chung KJ, Chang YC, Chen H-M, et al. Involvement of human CD44 during Cryptococcus neoformans infection of brain microvascular endothelial cells. Cell Microbiol. 2008;10(6):1313\u201326.","journal-title":"Cell Microbiol"},{"issue":"40","key":"9895_CR51","doi-asserted-by":"publisher","first-page":"34761","DOI":"10.1074\/jbc.M111.219378","volume":"286","author":"SH Huang","year":"2011","unstructured":"Huang SH, Long M, Wu CH, Kwon-Chung KJ, Chang YC, Chi F, et al. Invasion of Cryptococcus neoformans into human brain microvascular endothelial cells is mediated through the lipid rafts-endocytic pathway via the dual specificity tyrosine phosphorylation-regulated kinase 3 (DYRK3). J Biol Chem. 2011;286(40):34761\u20139.","journal-title":"J Biol Chem"},{"issue":"1","key":"9895_CR52","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1423-0127-19-19","volume":"19","author":"M Long","year":"2012","unstructured":"Long M, Huang SH, Wu CH, Shackleford GM, Jong A. Lipid raft\/caveolae signaling is required for Cryptococcus neoformans invasion into human brain microvascular endothelial cells. J Biomed Sci. 2012;19(1):19.","journal-title":"J Biomed Sci"},{"issue":"8","key":"9895_CR53","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1128\/EC.00120-07","volume":"6","author":"A Jong","year":"2007","unstructured":"Jong A, Wu CH, Chen HM, Luo F, Kwon-Chung KJ, Chang YC, et al. Identification and characterization of CPS1 as a hyaluronic acid synthase contributing to the pathogenesis of Cryptococcus neoformans infection. Eukaryot Cell. 2007;6(8):1486\u201396.","journal-title":"Eukaryot Cell"},{"issue":"9","key":"9895_CR54","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1128\/IAI.72.9.4985-4995.2004","volume":"72","author":"YC Chang","year":"2004","unstructured":"Chang YC, Stins MF, McCaffery MJ, Miller GF, Pare DR, Dam T, et al. Cryptococcal yeast cells invade the Central Nervous System via Transcellular Penetration of the blood-brain barrier. Infect Immun. 2004;72(9):4985\u201395.","journal-title":"Infect Immun"},{"issue":"8","key":"9895_CR55","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/nrmicro1952","volume":"6","author":"KS Kim","year":"2008","unstructured":"Kim KS. Mechanisms of microbial traversal of the blood\u2013brain barrier. Nat Rev Microbiol. 2008;6(8):625\u201334.","journal-title":"Nat Rev Microbiol"},{"issue":"10","key":"9895_CR56","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1111\/j.1462-5822.2012.01819.x","volume":"14","author":"R Maruvada","year":"2012","unstructured":"Maruvada R, Zhu L, Pearce D, Zheng Y, Perfect J, Kwon-Chung KJ, et al. Cryptococcus neoformans phospholipase B1 activates host cell Rac1 for traversal across the blood-brain barrier. Cell Microbiol. 2012;14(10):1544\u201353.","journal-title":"Cell Microbiol"},{"key":"9895_CR57","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12929-016-0247-2","volume":"23","author":"X He","year":"2016","unstructured":"He X, Shi X, Puthiyakunnon S, Zhang L, Zeng Q, Li Y, et al. CD44-mediated monocyte transmigration across Cryptococcus neoformans-infected brain microvascular endothelial cells is enhanced by HIV-1 gp41-I90 ectodomain. J Biomed Sci. 2016;23:28.","journal-title":"J Biomed Sci"},{"issue":"2","key":"9895_CR58","doi-asserted-by":"publisher","first-page":"e57430","DOI":"10.1371\/journal.pone.0057430","volume":"8","author":"C Deboux","year":"2013","unstructured":"Deboux C, Ladraa S, Cazaubon S, Ghribi-Mallah S, Weiss N, Chaverot N, et al. Overexpression of CD44 in neural precursor cells improves trans-endothelial migration and facilitates their invasion of perivascular tissues in vivo. PLoS ONE. 2013;8(2):e57430.","journal-title":"PLoS ONE"},{"key":"9895_CR59","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1186\/1471-2407-12-458","volume":"12","author":"S Hiscox","year":"2012","unstructured":"Hiscox S, Baruha B, Smith C, Bellerby R, Goddard L, Jordan N, et al. Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan. BMC Cancer. 2012;12:458.","journal-title":"BMC Cancer"},{"issue":"2","key":"9895_CR60","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s11060-019-03288-8","volume":"145","author":"C Hou","year":"2019","unstructured":"Hou C, Ishi Y, Motegi H, Okamoto M, Ou Y, Chen J, et al. Overexpression of CD44 is associated with a poor prognosis in grade II\/III gliomas. J Neurooncol. 2019;145(2):201\u201310.","journal-title":"J Neurooncol"},{"issue":"3","key":"9895_CR61","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1177\/1724600817746951","volume":"33","author":"Y Liu","year":"2018","unstructured":"Liu Y, Wu T, Lu D, Zhen J, Zhang L. CD44 overexpression related to lymph node metastasis and poor prognosis of pancreatic cancer. Int J Biol Markers. 2018;33(3):308\u201313.","journal-title":"Int J Biol Markers"},{"issue":"1","key":"9895_CR62","first-page":"64","volume":"30","author":"J Grisar","year":"2012","unstructured":"Grisar J, Munk M, Steiner CW, Amoyo-Minar L, Tohidast-Akrad M, Zenz P, et al. Expression patterns of CD44 and CD44 splice variants in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2012;30(1):64\u201372.","journal-title":"Clin Exp Rheumatol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09895-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-09895-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09895-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T07:02:02Z","timestamp":1726815722000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-09895-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,20]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["9895"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-09895-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,20]]},"assertion":[{"value":"22 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study conformed to the ethical guidelines of the Declaration of Helsinki and was approved by The Ethics Committee of The First Affiliated Hospital with Nanjing Medical University. With the approval of the Ethics Committee (protocol 2021-SR-566), informed consent was waived because of the retrospective nature of the study, and the analysis used anonymous clinical data. Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1018"}}